Saakshi Medtech & Panels Ltd
SAAKSHI NSE
Saakshi Medtech & Panels Ltd
IndustrialsNSE: SAAKSHI Electrical Equipment
Key Fundamentals
SMEOther Electrical EquipmentCapital GoodsMarket Cap
₹526 Cr
Volatility
Moderate
P/E Ratio
42.7
EBITDA
₹10.90 Cr
Return on Equity
4.8%
Debt to Equity
0.23
Book Value
₹62.49
52W High
₹331
52W Low
₹147.4
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Saakshi Medtech & Panels Ltd insights
41 extracted metrics + investor summaries across FY20–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Weaknesses
4- Stock is trading at 4.75 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 10.6% over last 3 years.
- Company might be capitalizing the interest cost
Growth Rate
Revenue Growth
-24.14% ↘
Net Income Growth
-58.41% ↘
Cash Flow Change
-59.79% ↘
ROE
-60.36% ↘
ROCE
-58.83% ↘
EBITDA Margin (Avg.)
-29.77% ↘
Quarterly Results
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 69 | 61 | 61 | 44 | 48 | 58 | 57 |
| Expenses | 57 | 52 | 50 | 38 | 44 | 48 | 46 |
| Operating Profit | 12 | 10 | 10 | 6 | 4 | 11 | 12 |
| OPM % | 17% | 16% | 17% | 15% | 8% | 18% | 20% |
| Other Income | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
| PBT | 10 | 7 | 8 | 5 | 2 | 9 | 8 |
| Tax % | 26% | 23% | 25% | 28% | 30% | 25% | 28% |
| Net Profit | 7 | 6 | 6 | 3 | 1 | 7 | 6 |
| EPS in Rs | — | 3.14 | 3.4 | 1.95 | 0.71 | 3.76 | 3.21 |
Profit & Loss
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 61 | 60 | 92 | 122 | 122 | 92 | 116 |
| Expenses | 50 | 54 | 76 | 101 | 102 | 82 | 93 |
| Operating Profit | 11 | 6 | 16 | 21 | 20 | 10 | 22 |
| OPM % | 18% | 10% | 17% | 17% | 16% | 11% | 19% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Interest | 2 | 1 | 1 | 1 | 2 | 0 | 1 |
| Depreciation | 2 | 2 | 2 | 3 | 4 | 4 | 5 |
| PBT | 8 | 3 | 13 | 17 | 15 | 7 | 17 |
| Tax % | 24% | 33% | 26% | 25% | 24% | 28% | 26% |
| Net Profit | 6 | 2 | 9 | 12 | 11 | 5 | 12 |
| EPS in Rs | — | — | — | — | 6.41 | 2.67 | 6.96 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 18 | 18 | 18 |
| Reserves | 15 | 18 | 27 | 40 | 76 | 80 | 93 |
| Borrowings | 19 | 22 | 16 | 20 | 18 | 18 | 25 |
| Other Liabilities | 11 | 14 | 19 | 31 | 19 | 15 | 21 |
| Total Liabilities | 48 | 56 | 65 | 93 | 131 | 131 | 157 |
| Fixed Assets | 22 | 22 | 26 | 34 | 62 | 60 | 83 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 13 | 10 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 26 | 34 | 39 | 59 | 68 | 58 | 64 |
| Total Assets | 48 | 56 | 65 | 93 | 131 | 131 | 157 |
Cash Flow
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Operating | 11 | 0 | 11 | 11 | 8 | 3 | 18 |
| Investing | -6 | -1 | -5 | -11 | -31 | -15 | -25 |
| Financing | -3 | 2 | -7 | 2 | 36 | -1 | 6 |
| Net Cash Flow | 2 | 1 | -1 | 2 | 12 | -12 | -1 |
| Free Cash Flow | 4 | -1 | 5 | 0 | -24 | -12 | -8 |
| CFO/OP | 115 | 28 | 87 | 73 | 64 | 50 | 100 |
Ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 62 | 90 | 70 | 69 | 52 | 86 | 83 |
| Inventory Days | 74 | 95 | 81 | 109 | 102 | 129 | 122 |
| Days Payable | 73 | 97 | 83 | 93 | 43 | 50 | 60 |
| Cash Conversion Cycle | 63 | 88 | 67 | 84 | 110 | 165 | 144 |
| Working Capital Days | -5 | 7 | 30 | 36 | 88 | 129 | 94 |
| ROCE % | — | 12% | 32% | 33% | 19% | 6% | 14% |
Documents
1
Disclosure of material issue
7 Aug - NSE granted in-principle approval for 20,22,940 preferential shares at Rs.207 each on August 6, 2026. 7 Aug - NSE granted in-principle approval for 20,22,940 preferential shares at Rs.207 each on August 6, 2026.
2
General Updates
17 Jul - Updated valuation report received for preferential issue; issue price and swap terms unchanged. 17 Jul - Updated valuation report received for preferential issue; issue price and swap terms unchanged.
3
General Updates
17 Jul - Submitted Regulation 74(5) certificate for quarter ended June 30, 2026; all shares in demat form. 17 Jul - Submitted Regulation 74(5) certificate for quarter ended June 30, 2026; all shares in demat form.
4
Structural Digital Database
29 Jun - SDD compliance certificate filed for 1 April 2026 to 26 June 2026; no non-compliance reported. 29 Jun - SDD compliance certificate filed for 1 April 2026 to 26 June 2026; no non-compliance reported.
5
General Updates
22 Jun - June 22, 2026 corrigendum fixes allottee names and PESB Alpha Fund UBO; issue terms unchanged. 22 Jun - June 22, 2026 corrigendum fixes allottee names and PESB Alpha Fund UBO; issue terms unchanged.
Frequently Asked Questions about Saakshi Medtech & Panels Ltd
What does Saakshi Medtech & Panels Ltd do?
Incorporated in 2009, Saakshi Medtech
& Panels Ltd deals in Electrical Control
Panels, Medical X-Ray Systems,
Fabrication & Wire Harness[1]
Where is Saakshi Medtech & Panels Ltd (SAAKSHI) listed?
Saakshi Medtech & Panels Ltd is listed on the Indian stock exchanges. It is listed on NSE: SAAKSHI. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Saakshi Medtech & Panels Ltd belong to?
Saakshi Medtech & Panels Ltd operates in the Industrials sector within the Electrical Equipment industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Saakshi Medtech & Panels Ltd?
Saakshi Medtech & Panels Ltd has a market capitalisation of approximately ₹526.15 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Saakshi Medtech & Panels Ltd?
The Price-to-Earnings (PE) ratio of Saakshi Medtech & Panels Ltd is 42.70. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Saakshi Medtech & Panels Ltd?
Over the past 52 weeks, Saakshi Medtech & Panels Ltd has traded between a low of ₹147.4 and a high of ₹331. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of Saakshi Medtech & Panels Ltd?
Saakshi Medtech & Panels Ltd has a Return on Equity (ROE) of 4.80%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Saakshi Medtech & Panels Ltd on Tapetide?
On Tapetide, you can view Saakshi Medtech & Panels Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 2009, Saakshi Medtech & Panels Ltd deals in Electrical Control Panels, Medical X-Ray Systems, Fabrication & Wire Harness[1]